BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Herpain A, Bouchez S, Girardis M, Guarracino F, Knotzer J, Levy B, Liebregts T, Pollesello P, Ricksten SE, Riha H, Rudiger A, Sangalli F. Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper. J Cardiovasc Pharmacol 2019;73:3-14. [PMID: 30489437 DOI: 10.1097/FJC.0000000000000636] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Grześk G, Wołowiec Ł, Rogowicz D, Gilewski W, Kowalkowska M, Banach J, Hertmanowski W, Dobosiewicz M. The importance of pharmacokinetics, pharmacodynamic and repetitive use of levosimendan. Biomedicine & Pharmacotherapy 2022;153:113391. [DOI: 10.1016/j.biopha.2022.113391] [Reference Citation Analysis]
2 Wang Z, Bian W, Yan Y, Zhang D. Functional Regulation of KATP Channels and Mutant Insight Into Clinical Therapeutic Strategies in Cardiovascular Diseases. Front Pharmacol 2022;13:868401. [DOI: 10.3389/fphar.2022.868401] [Reference Citation Analysis]
3 Kong X, Hu X, Hua B, Fedele F, Farmakis D, Pollesello P. Levosimendan in Europe and China: An Appraisal of Evidence and Context. Eur Cardiol 2021;16:e42. [PMID: 34815750 DOI: 10.15420/ecr.2021.41] [Reference Citation Analysis]
4 Luo JC, Zheng WH, Meng C, Zhou H, Xu Y, Tu GW, Luo Z, Huang HB. Levosimendan to Facilitate Weaning From Cardiorespiratory Support in Critically Ill Patients: A Meta-Analysis. Front Med (Lausanne) 2021;8:741108. [PMID: 34712681 DOI: 10.3389/fmed.2021.741108] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Wang YH, Chen JL, Tsai CS, Tsai YT, Lin CY, Ke HY, Hsu PS. Effects of Levosimendan on Systemic Perfusion in Patients with Low Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Score: Experience from a Single Center in Taiwan. Acta Cardiol Sin 2021;37:512-21. [PMID: 34584384 DOI: 10.6515/ACS.202109_37(5).20210310B] [Reference Citation Analysis]
6 Riessen R, Hellwege RS. [Pharmacological therapy of circulatory shock]. Med Klin Intensivmed Notfmed 2021;116:541-53. [PMID: 34338810 DOI: 10.1007/s00063-021-00838-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LMA, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RHG, Toller W, Tritapepe L, Tschöpe C, Wikström G, Lewinski DV, Vrtovec B, Pollesello P. Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use. J Cardiovasc Pharmacol 2020;76:4-22. [PMID: 32639325 DOI: 10.1097/FJC.0000000000000859] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Mauriat P, Bojan M, Soulie S, Foulgoc H, Tafer N, Ouattara A. Impact of the perioperative inotropic support in grown-up congenital heart patients undergoing cardiac surgery: a propensity score adjusted analysis. Ann Intensive Care 2020;10:91. [PMID: 32648069 DOI: 10.1186/s13613-020-00709-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF, Édes I, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Fruhwald S, Girardis M, Guarracino F, Harjola VP, Heringlake M, Herpain A, Heunks LM, Husebye T, Ivancan V, Karason K, Kaul S, Kivikko M, Kubica J, Masip J, Matskeplishvili S, Mebazaa A, Nieminen MS, Oliva F, Papp JG, Parissis J, Parkhomenko A, Põder P, Pölzl G, Reinecke A, Ricksten SE, Riha H, Rudiger A, Sarapohja T, Schwinger RH, Toller W, Tritapepe L, Tschöpe C, Wikström G, von Lewinski D, Vrtovec B, Pollesello P. Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use. Card Fail Rev 2020;6:e19. [PMID: 32714567 DOI: 10.15420/cfr.2020.03] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
10 L'Heureux M, Sternberg M, Brath L, Turlington J, Kashiouris MG. Sepsis-Induced Cardiomyopathy: a Comprehensive Review. Curr Cardiol Rep 2020;22:35. [PMID: 32377972 DOI: 10.1007/s11886-020-01277-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
11 Severino P, D'Amato A, Pucci M, Infusino F, Birtolo LI, Mariani MV, Lavalle C, Maestrini V, Mancone M, Fedele F. Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels. Int J Mol Sci 2020;21:E3167. [PMID: 32365863 DOI: 10.3390/ijms21093167] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 14.5] [Reference Citation Analysis]
12 Grossini E, Farruggio S, Pierelli D, Bolzani V, Rossi L, Pollesello P, Monaco C. Levosimendan Improves Oxidative Balance in Cardiogenic Shock/Low Cardiac Output Patients. J Clin Med 2020;9:E373. [PMID: 32019057 DOI: 10.3390/jcm9020373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
13 Villa G, Tavazzi G, Guarracino F, Sangalli F. Levosimendan: What Have We Learned So Far? Curr Anesthesiol Rep 2019;9:234-41. [DOI: 10.1007/s40140-019-00346-9] [Reference Citation Analysis]